Back to search results

Mobile Health Interventions for Heart Disease After Hypertensive Pregnancy

This study is looking at how digital health tools can help prevent heart disease in women who had high blood pressure during pregnancy (Hypertensive Disorders of Pregnancy, or HDP, which includes pre-eclampsia, eclampsia, or gestational hypertension). Researchers are testing a Digital Blood Pressure Monitoring System and a Mobile health application. You might be able to join if you are a woman aged 18 to 99 who delivered at Northwestern Memorial Hospital (Prentice Women's Hospital) and had new-onset HDP. The study aims to see if these interventions can lower your systolic blood pressure at 3 and 12 months after delivery. The current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 120 participants. Participants will be randomly assigned to either receive the digital health interventions or usual care.
What's involved
You would have an echocardiogram and your blood pressure/weight measured at 3 months and 12 months postpartum. If in the intervention group, you would use a mobile health application and a digital blood pressure monitoring system at home for one year.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months postpartum, with primary endpoints measured at 3 and 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06523569

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

Active, Not Recruiting
NAAges 18–99InterventionalPrevention
Northwestern University
~120 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Digital Blood Pressure Monitoring SystemMobile health application

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Systolic blood pressure
Measured over 3 months postpartum; 12 months postpartum

Conditions

Hypertension in Pregnancy
Pre-Eclampsia
Eclampsia
Gestational Hypertension

Explore related trials

Toxemia of Pregnancy

NCT06523569

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Northwestern University, Dept. of Cardiology

    Chicago, Illinoisno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Priya M Freaney, MD · PRINCIPAL_INVESTIGATOR · Northwestern University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Delivery at Northwestern Memorial Hospital (Prentice Women's Hospital)
Live birth at any gestational age
Pregnancy complicated by new-onset HDP (pre-eclampsia, eclampsia, or gestational hypertension)

Exclusion

HELLP syndrome
History of chronic diseases pre-pregnancy (hypertension, diabetes, cardiovascular disease, chronic renal disease)
Current Omron remote patient monitoring or Noom user
BMI\<18.5 kg/m2 at enrollment
Inadequate gestational weight gain or gestational weight loss

What this trial measures

  • Systolic blood pressure3 months postpartum; 12 months postpartum

    All participants will have systolic blood pressure measured at 3 months and 12 months postpartum